|
Volumn 24, Issue 10, 2013, Pages 1125-1129
|
Cardiovascular implantable electronic device implantation with uninterrupted dabigatran: comparison to uninterrupted warfarin
a a a a a a a a a |
Author keywords
cardiovascular implantable electronic device (CIED); dabigatran; implantable cardioverter defibrillator; pacemaker; warfarin
|
Indexed keywords
ANTICOAGULANT AGENT;
ANTITHROMBOCYTIC AGENT;
BENZIMIDAZOLE DERIVATIVE;
BETA ALANINE;
DABIGATRAN;
WARFARIN;
ADVERSE EFFECTS;
AGED;
ANALOGS AND DERIVATIVES;
ARTIFICIAL HEART PACEMAKER;
BLEEDING;
CARDIOVERSION;
CHEMICALLY INDUCED;
COMPARATIVE STUDY;
DEVICE REMOVAL;
DEVICES;
DRUG ADMINISTRATION;
FEMALE;
HEART PACING;
HUMAN;
IMPLANTABLE CARDIOVERTER DEFIBRILLATOR;
INTERNATIONAL NORMALIZED RATIO;
MALE;
MIDDLE AGED;
PROSTHESIS IMPLANTATION;
REOPERATION;
RETROSPECTIVE STUDY;
RISK FACTOR;
TIME;
TREATMENT OUTCOME;
VERY ELDERLY;
AGED;
AGED, 80 AND OVER;
ANTICOAGULANTS;
BENZIMIDAZOLES;
BETA-ALANINE;
CARDIAC PACING, ARTIFICIAL;
DEFIBRILLATORS, IMPLANTABLE;
DEVICE REMOVAL;
DRUG ADMINISTRATION SCHEDULE;
ELECTRIC COUNTERSHOCK;
FEMALE;
HEMORRHAGE;
HUMANS;
INTERNATIONAL NORMALIZED RATIO;
MALE;
MIDDLE AGED;
PACEMAKER, ARTIFICIAL;
PLATELET AGGREGATION INHIBITORS;
PROSTHESIS IMPLANTATION;
REOPERATION;
RETROSPECTIVE STUDIES;
RISK FACTORS;
TIME FACTORS;
TREATMENT OUTCOME;
WARFARIN;
|
EID: 85027945311
PISSN: None
EISSN: 15408167
Source Type: Journal
DOI: 10.1111/jce.12214 Document Type: Article |
Times cited : (40)
|
References (0)
|